Living Pharma

Baltimore, United States Founded: 2015 • Age: 11 yrs Acquired By Lentigen
Personalized anti-tag CAR T cell therapies for cancer are developed.
Request Access

About Living Pharma

Living Pharma is a company based in Baltimore (United States) founded in 2015 was acquired by Lentigen in July 2017.. Living Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, Insitro, BridgeBio, Celgene and ATAI, among others.

  • Headquarter Baltimore, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Lentigen

    (Jul 20, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Living Pharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Living Pharma

Living Pharma has secured backing from 1 investor. Prominent investors backing the company include Lentigen. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Lentiviral vectors are developed for pre-clinical and clinical applications.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Living Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Living Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Living Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Living Pharma

Living Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Insitro, BridgeBio, Celgene and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
An AI-enabled platform is developed for infectious disease treatment.
domain founded_year HQ Location
Therapeutics for genetic diseases are developed through targeted interventions.
domain founded_year HQ Location
Therapies for cancer and inflammatory diseases are developed.
domain founded_year HQ Location
A biopharmaceutical company accelerating innovative mental health treatments.
domain founded_year HQ Location
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Living Pharma

Frequently Asked Questions about Living Pharma

When was Living Pharma founded?

Living Pharma was founded in 2015.

Where is Living Pharma located?

Living Pharma is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.

What does Living Pharma do?

Living Pharma develops personalised CAR T Cell therapies to treat cancer. They are focused on developing therapeutic immuno-oncology products optimised for each individual patient. The companys Universal Anti-Tag Chimeric Antigen Receptor (AT-CAR) engineered T cell can be tailored to each individual patients cancer and disease phenotype. AT-CAR T cells recognize a tagged tumor-targeting molecule (which could be an anti-tumor MAb, Soluble T Cell Receptor, or a Cytokine). The companys universal AT-CAR T cells target and eradicate multiple cancer types through the use of a panel of ATCs, each ATC recognizing a unique tumor-associated antigen.

Who are the top competitors of Living Pharma?

Living Pharma's top competitors include Jazz Pharmaceuticals, Spark Therapeutics and BridgeBio.

Who are Living Pharma's investors?

Living Pharma has 1 investor. Key investors include Lentigen.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available